Remove Licensing Remove Marketing Remove Packaging Remove Regulation
article thumbnail

Animals Need Drugs Too, But Not Without CVM Approval

FDA Law Blog

Palmer & Riëtte van Laack — Most of us love our furry friends, and with the boom in pet ownership during the pandemic, it is no surprise that the market for pet products has become enormous. CVM does not regulate the practice of veterinary medicine (that’s a state licensing board) or vaccines for animal diseases (that’s USDA).

Drugs 59
article thumbnail

Regulatory Strategy Considerations for Working with the FDA vs the EMA, Part 1

Camargo

As regulatory requirements become increasingly harmonized across the globe, the development and marketing of pharmaceutical products worldwide are also becoming more streamlined. As of January 1, 2021 , EU pharmaceutical regulations do not apply to the United Kingdom, which formally left the EU in January 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer Receives Positive CHMP Opinion for Conversion of PAXLOVID™ Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Pfizer

One carton contains five blister packs of PAXLOVID, as co-packaged nirmatrelvir tablets with ritonavir tablets, providing all required doses for a full five-day treatment course. The dose for patients with moderate renal impairment (eGFR ≥30 to For more information, please visit www.PAXLOVID.com.

article thumbnail

PDUFA VII: More Changes Coming in the Latest Reauthorization

Camargo

PDUFA VII will establish a new process, timelines, and associated performance goals for post-marketing requirements (PMRs) during pre-approval and a new process for the review of existing PMRs post-approval. Receipt of Background Package. Response Time. calendar days). Meeting Scheduling or Written Response Time. EOP = end of phase.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

article thumbnail

Biopharma Packaging Requirements: What You Need to Know

Pharma Packaging Solutions

The biopharmaceutical market is ever growing, thanks to constant scientific advancements in the field. As biopharma products become more common, so must biopharma packaging. Due to the sensitive nature of many biological products, there are strict federal regulations in place to ensure safe packaging and distribution.

article thumbnail

How to Select best PCD Pharma Franchisee Distributor

Creogenic Pharma

Knowledge of which areas are covered by the company and which are still vacant, different types of packaging available, and any unique products that the company offers can also be valuable information to have when communicating with potential franchisee distributors. Regular income with high experience of market working and conditioning.